Skip Navigation

A Phase I Open-Label, Safety, Pharmacokinetic and Preliminary Efficacy Study of STRO-001, an anti-CD74 Antibody Drug Conjugate, in Patients with Advanced B-Cell Malignancies

Brief Summary

Type:
Other

Study Type:
Treatment

Phase:
I

ClinicalTrials.gov Identifier:
NCT03424603

Study #:
STUDY00145038

Start Date:
Apr 07, 2020

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT03424603

View Complete Trial Details & Eligibility at ClinicalTrials.gov